|
Model Number THP-M |
Device Problems
Difficult to Remove (1528); Detachment of Device or Device Component (2907); Material Deformation (2976)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 04/05/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
A turbohawk plus was being used for the treatment of 80mm and 50mm lesions with chronic total occlusion in the iliac artery - common and superficial femoral artery (sfa).The lesions were calcified and fibrous.There was no tortuosity and calcification was severe.A 6fr non medtronic sheath and a 5mm spider fx were used.The vessel was not pre or post dilated.The ifu was followed.The guidewire was hydrated at preparation.The device was advanced over the bifurcation.Tip damage was reported.It was reported the physician shaved the right sfa, cleaned the device, reinserted and shaved more.During withdrawal to clean device extreme resistance was felt in the right cfa.Further pulling of device caused sheath to come back into left common iliac artery, & the device became stuck over aortic bifurcation with the distal part in right common iliac artery and the proximal part with cutter window in left common iliac artery.The patient was transported to hospital for possible surgical cut down.Further attempts to dislodge device & snare were successful & cut down was not needed.The patient was kept overnight for observation.
|
|
Manufacturer Narrative
|
Product analysis a visual inspection showed that the tip/housing detached distal to the anchor pockets the detached tip was returned on the detached distal end of a spider fx device.The guidewire lumen on the housing is ripped, the proximal end of the spider fx wire was also returned, and one end of the wire is kinked the spider fx wire is confirmed as 0.014¿ product analysis images 1 and 2 appear to show the patients vasculature with contrast.Image 3 appears to show a n atherectomy device in the patient¿s vasculature.It appears that the housing/tip is detached from the de vice, and i still connected by the drive shaft.Image 4 appears to show an atherectomy device advancing out of an introducer sheath.The guidewire loaded through the device appears to have prolapsed.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Additional information: the damaged component did not remain attached.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|